Antleron

Antleron

Foundation date

2014

Sector

#Biotechnology / R&D Services

Subsector

• #R&D Services - CRO (Contract Research Organization)

Therapeutic areas

• #Cardiovascular
• #Digestive system
• #Diseases of the blood and blood-forming organs - immune disorders
• #Injury - poisoning and certain other consequences of external causes
• #Musculoskeletal system and connective tissue
• #Skin and subcutaneous tissue
• #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified

We are Antleron, a nimble team that will revolutionise medicine by leading the development of next generation advanced therapies and medical devices. By merging the potential of cells, biomaterials, biologics, 3D printing and bioreactors we will accelerate the engineering of medicinal products, devices and processes that will change health care and result in a better life for all. The Antleron business philosophy is to create sustainable ventures through risk & reward sharing partnerships.